Biography 

1. Research Areas

     Cardiovascular Disease

2. Education

2004.9-2009.7, PhD in School of Medicine, Major in Molecular Biology, Jilin University

3. Professional Experience

2015.1- Present, Associate Professor in School of Medicine, Nankai University

2009.7-2014.12, Lecture in School of Medicine, Nankai University

Research & Achievements

Research Achievements

Peer-Reviewed Journal Papers

1．Ren Jiling, Yang Lei, Tian Wencong, Zhu Mengmeng, Liu Jie, Lu Ping, Li Jing, Yang Liang, Qi Zhi.Nitric Oxide Synthase Inhibition Abolishes Exercise-Mediated Protection against Isoproterenol-Induced Cardiac Hypertrophy in Female Mice. Cardiology. 2015;130(3):175-84.

2．Liang Yang, Zhe Jia, Lei Yang, Mengmeng Zhu, Jincai Zhang, Jie Liu, Ping Wu, Wencong Tian, Jing Li, Zhi Qi, Xiangdong Tang. Exercise Protects against Chronic β-Adrenergic Remodeling of the Heart by Activation of Endothelial Nitric Oxide Synthase. PLoS One. 2014 May 8;9(5):e96892. doi: 10.1371/journal.pone.0096892.

3．Lei Yang, Liang Yang(co-first author), Wencong Tian, Jing Li, Jie Liu, Mengmeng Zhu, Yuan Zhang, Yinan Yang, Fei Liu, QIong Zhang, Qi Liu, Yanna Shen, Zhi Qi. Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol. 2014 May;140(5):749-55. doi: 10.1007/s00432-014-1624

4．Liang Yang, Xiangyu Cai, Jie Liu, Zhe Jia, Jinjin Jiao, Jincai Zhang, Changlin Li, Jing Li, Xiangdong Tang. CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling. PLoS One. 2013 Apr 30;8(4):e62373. doi: 10.1371/journal.pone.0062373.

5．Liang Yang, Xiuli Wu, Min Wan, Yue Yu, Yongli Yu, Liying Wang. CpG oligodeoxynucleotides with double stem-loops show strong immunostimulatory activity. International Immunopharmacology, 2013, Jan;15(1):89-96. doi: 10.1016/j.intimp.2012.10.020. Epub 2012 Nov 7

6．Jiling Ren, Liang Yang, Haifei Xu, Min Wan, Guoying Liu, Lixia Zhao, Yongli Yu, Liying Wang. A bovine favored CpG ODN oligodeoxynucleotide and Montanide ISA 206 adjuvant combination augment the immune responses of a recombinant FMDV vaccine in cattle. Vaccine, 2011, 29(45): 7960-7965.

Projects

Projects

[1]   Structure function relationships and molecular mechanisms of CpG ODN as anti-cardiac hypertrophy agent，12JCQNJC08300，2012.4-2015.3

[2]  Molecular mechanisms of CpG ODN as anti-cardiac hypertrophy agent，NSFC，81102436，2012.1-2014.12

Teaching

Teaching

[1] Master: Lifeng Feng